AVIGEN INC \DE
Healthcare · In Vitro & In Vivo Diagnostic Substances · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Director / officer changeDec 16, 2009
- Regulation FD disclosureAug 26, 2009
- Entered a material agreement · Modified shareholder rightsAug 25, 2009
- Results of operationsAug 11, 2009
- Other material eventJun 25, 2009
- Results of operationsMay 11, 2009
- Director / officer change · Other material eventApr 22, 2009
- Other material eventApr 1, 2009
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- UPLOADJan 21, 2010
- SC 13D/AAMENDMENT NO. 9 TO THE SCHEDULE 13DDec 24, 2009
- 4PRIMARY DOCUMENTDec 22, 2009
- 4PRIMARY DOCUMENTDec 22, 2009
- 4PRIMARY DOCUMENTDec 22, 2009
- 4PRIMARY DOCUMENTDec 22, 2009
- 4PRIMARY DOCUMENTDec 22, 2009
- 4PRIMARY DOCUMENTDec 22, 2009
- SC 13G/ADec 22, 2009
- 4PRIMARY DOCUMENTDec 21, 2009
- 4PRIMARY DOCUMENTDec 21, 2009
- 4PRIMARY DOCUMENTDec 21, 2009
- 25-NSEDec 21, 2009
- 15-12GCERTIFICATION OF TERMINATION OF REGISTRATIONDec 21, 2009
- 4DECEMBER 16, 2009Dec 16, 2009
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.